glp 1 analog drugs GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Top GLP-1 Agonists Balance Weight

Impact of GLP-1 and GLP-1 receptor agonists on cardiovascular risk factors in type 2 diabetes

Future Potential : The robust pipeline of increasingly effective agents, combined with emerging oral formulations and potential cost reduction strategies, suggests that current limitations may be surmountable with continued innovation and policy development

The rising prevalence of type 2 diabetes mellitus and obesity, rising adoption of technology, and increasing investments drive the market

Motor performance and functionality improvements were seen, with a lower disability score observed in the intranasal insulin group compared to baseline scores, suggesting that intranasal insulin may be a feasible treatment for PD

British Journal of Pharmacology, 39 (1), 16.